Literature DB >> 11263500

Frequent loss of 1p32 region but no mutation of the p18 tumor suppressor gene in meningiomas.

P Leuraud1, Y Marie, E Robin, S Huguet, J He, K Mokhtari, P Cornu, K Hoang-Xuan, M Sanson.   

Abstract

After chromosome 22 and NF2 inactivation, the loss of chromosome 1p is one of the most frequent abnormalities encountered in meningiomas. However the putative tumor suppressor gene located on 1p inactivated in meningiomas has still to be identified. We screened 68 meningiomas for LOH on chromosome 22 and 1. We found 34 LOH on the NF2 region on chromosome 22 (50%) and 19 LOH on 1p (28%), 16 being associated with loss of chromosome 22. Partial deletions delimited a candidate region located between D1S234 and D1S2797. The p18INK4C tumor suppressor gene, a member of the genes family coding for inhibitors of cyclin-dependent kinases, is located in this region. To determine whether p18 is involved in development of meningiomas, we performed a mutation analysis of the p18 gene and a search for homozygous deletion in the 19 meningiomas with 1p loss. Sequencing analysis of the p18 gene revealed one polymorphism, but no somatic mutations and no homozygous deletions were found. These results confirm that the loss of chromosome 1p32 is a frequent feature in meningiomas, however the p18 tumor suppressor gene which is located in this region, does not seem to be involved.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11263500     DOI: 10.1023/a:1006400723490

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  30 in total

1.  Characterisation of 16 polymorphic markers in the NF2 gene: application to hemizygosity detection.

Authors:  P Legoix; M F Legrand; E Ollagnon; G Lenoir; G Thomas; J Zucman-Rossi
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

2.  Analysis of the p16INK4A, p15INK4B and p18INK4C genes in multiple myeloma.

Authors:  T Tasaka; J Berenson; R Vescio; T Hirama; C W Miller; M Nagai; J Takahara; H P Koeffler
Journal:  Br J Haematol       Date:  1997-01       Impact factor: 6.998

3.  Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.

Authors:  M Schreiber; W J Muller; G Singh; F L Graham
Journal:  Oncogene       Date:  1999-03-04       Impact factor: 9.867

4.  Chromosomal consitution of meningiomas.

Authors:  K D Zang; H Singer
Journal:  Nature       Date:  1967-10-07       Impact factor: 49.962

5.  Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma.

Authors:  A Iolascon; M F Faienza; B Coppola; A Rosolen; G Basso; F Della Ragione; F Schettini
Journal:  Genes Chromosomes Cancer       Date:  1996-04       Impact factor: 5.006

6.  Homozygous deletions of the CDKN2C/p18INK4C gene on the short arm of chromosome 1 in anaplastic oligodendrogliomas.

Authors:  U Pohl; J G Cairncross; D N Louis
Journal:  Brain Pathol       Date:  1999-10       Impact factor: 6.508

7.  Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.

Authors:  M H Ruttledge; J Sarrazin; S Rangaratnam; C M Phelan; E Twist; P Merel; O Delattre; G Thomas; M Nordenskjöld; V P Collins
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

8.  Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas.

Authors:  P Mérel; K Hoang-Xuan; M Sanson; A Moreau-Aubry; E K Bijlsma; C Lazaro; J P Moisan; F Resche; I Nishisho; X Estivill
Journal:  Genes Chromosomes Cancer       Date:  1995-07       Impact factor: 5.006

9.  Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancer.

Authors:  A Blais; Y Labrie; F Pouliot; Y Lachance; C Labrie
Journal:  Biochem Biophys Res Commun       Date:  1998-06-09       Impact factor: 3.575

10.  Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers.

Authors:  M R Rusin; A Okamoto; M Chorazy; K Czyzewski; J Harasim; E A Spillare; K Hagiwara; S P Hussain; Y Xiong; D J Demetrick; C C Harris
Journal:  Int J Cancer       Date:  1996-03-15       Impact factor: 7.396

View more
  7 in total

1.  Absence of histological signs of tumor progression in recurrences of completely resected meningiomas.

Authors:  Davide Schiffer; Chiara Ghimenti; Valentina Fiano
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

2.  Loss of heterozygosity at 1p, 7q, 17p, and 22q in meningiomas.

Authors:  In Bok Chang; Byung Moon Cho; Seung Myung Moon; Se Hyuck Park; Sae Moon Oh; Seong Jin Cho
Journal:  J Korean Neurosurg Soc       Date:  2010-07-31

3.  Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue.

Authors:  Wolfgang K Pfisterer; Stephen W Coons; Fahmy Aboul-Enein; William P Hendricks; Adrienne C Scheck; Mark C Preul
Journal:  J Neurooncol       Date:  2007-11-30       Impact factor: 4.130

4.  Loss of heterozygosity on chromosome 10q22-10q23 and 22q11.2-22q12.1 and p53 gene in primary hepatocellular carcinoma.

Authors:  Guang-Neng Zhu; Li Zuo; Qing Zhou; Su-Mei Zhang; Hua-Qing Zhu; Shu-Yu Gui; Yuan Wang
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

5.  Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone.

Authors:  Angel Maillo; Alberto Orfao; Ana B Espinosa; José María Sayagués; Marta Merino; Pablo Sousa; Monica Lara; María Dolores Tabernero
Journal:  Neuro Oncol       Date:  2007-08-17       Impact factor: 12.300

6.  Molecular biology of unreresectable meningiomas: implications for new treatments and review of the literature.

Authors:  Jay Jagannathan; Rod J Oskouian; Hian Kwang Yeoh; Dwight Saulle; Aaron S Dumont
Journal:  Skull Base       Date:  2008-05

7.  Implications of a RAD54L polymorphism (2290C/T) in human meningiomas as a risk factor and/or a genetic marker.

Authors:  Paola E Leone; Marta Mendiola; Javier Alonso; César Paz-y-Miño; Angel Pestaña
Journal:  BMC Cancer       Date:  2003-03-04       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.